Trio | triple functional domain (PTPRF interacting)
Physiological systems
17 / 24 physiological systems tested
6 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system Embryo Growth/size/body region Hematopoietic system Mortality/aging
11 No significant impact
7 Not tested
Data collections
Gene metrics:4Significant phenotypes
3Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
impaired glucose tolerance | 1 supporting dataset | Trioem1(IMPC)H | heterozygote | Early adult | 2.29x10-5 | ||
increased neutrophil cell number | 1 supporting dataset | Trioem1(IMPC)H | heterozygote | Early adult | 1.04x10-6 | ||
preweaning lethality, complete penetrance | 1 supporting dataset | Trioem1(IMPC)H | homozygote | Early adult | N/A * | ||
abnormal embryo size | 1 supporting dataset | Trioem1(IMPC)H | homozygote | E18.5 | 3.36x10-5 |
| | | | | | | | | |
External links
No external links available for Trio.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Trioem1(IMPC)H | Exon Deletion | | mouse |
Triotm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector es cell |
Triotm1a(KOMP)Mbp | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector es cell |
Triotm1e(KOMP)Mbp | Targeted, non-conditional allele | | es cell |